Indaptus Therapeutics, Inc.
For the period ended Jul 16, 2026. Filed Jul 16, 2026.
View on SEC.govAbout this filing
What shareholders are asked to vote on at a company's meeting. It is where to find what directors and top executives are paid, and who owns the most shares.
Jul 16, 2026 · Filed Jul 16, 2026
Contents
Cover page
Show cover page
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
SCHEDULE 14A
(Rule 14a-101)
INFORMATION REQUIRED IN PROXY STATEMENT
SCHEDULE 14A INFORMATION
Proxy Statement Pursuant to Section 14(a) of the
Securities Exchange Act of 1934
(Amendment No. )
Filed by the Registrant ☒
Filed by a Party other than the Registrant ☐
Check the appropriate box:
| ☐ | Preliminary Proxy Statement |
|---|---|
| ☐ | Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) |
| ☒ | Definitive Proxy Statement |
| ☐ | Definitive Additional Materials |
| ☐ | Soliciting Material under §240.14a-12 |
(Name of Registrant as Specified in its Charter)
(Name of Person(s) Filing Proxy Statement, if Other Than the Registrant)
Payment of Filing Fee (Check all boxes that apply):
| ☒ | No fee required. |
|---|---|
| ☐ | Fee paid previously with preliminary materials. |
| ☐ | Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11. |
NOTICE & PROXY STATEMENT
Annual Meeting of Stockholders
August 10, 2026
10:00 a.m. (Eastern Time)
3 COLUMBUS CIRCLE, 15 TH FLOOR
NEW YORK, NY 10019
July 16, 2026
To Our Stockholders:
You are cordially invited to attend the 2026 Annual Meeting of Stockholders (the “Annual Meeting”) of Indaptus Therapeutics, Inc. (the “Company”) at 10:00 a.m. Eastern time, on Monday, August 10, 2026, and any postponement, adjournment or continuation thereof. We will hold the Annual Meeting in a virtual format via live webcast, which you can register in advance for at https://meeting.vstocktransfer.com/INDAPTUSAUG26.
Stockholders willNOT be able to attend the Annual Meeting in person. The Annual Meeting will be accessible only over the internet. Please see “Questions and Answers About the Meeting and Voting— What do I need to do now to vote at the Annual Meeting?” in the proxy statement (the “Proxy Statement”) accompanying this letter for information on how to attend and vote at the Annual Meeting.
We are making available to you the accompanying Notice of Annual Meeting (“Notice”), Proxy Statement and form of proxy card or voting instruction form on or about July 29, 2026. We have elected to utilize the “full set delivery” option of providing paper copies of all of our proxy materials by mail. Our proxy materials are also electronically available at https://ts.vstocktransfer.com/irhlogin/I-INDAPTUS. Additional details regarding admission to, and the business to be conducted at, the Annual Meeting are described in the accompanying Notice and Proxy Statement.
Only stockholders of record at the close of business on June 12, 2026 are entitled to notice of, and to vote at, the Annual Meeting.
Your vote is important. Regardless of whether you plan to attend the Annual Meeting, we hope that you will vote as soon as possible. You may vote over the internet or by mailing in a proxy card. Please review the instructions on the proxy card or voting instruction form regarding each of these voting options. Voting will ensure your representation at the Annual Meeting regardless of whether you attend the Annual Meeting.
Thank you for your support.
Sincerely,
/s/ Junyi Dai
Junyi Dai
Chief Executive Officer and Chairman of the Board
Table of Contents
| NOTICE OF ANNUAL MEETING OF STOCKHOLDERS | 1 |
|---|---|
| PROXY STATEMENT | 2 |
| QUESTIONS AND ANSWERS ABOUT THE 2026 Annual Meeting of Stockholders | 4 |
| PROPOSALS TO BE VOTED ON | 7 |
| REPORT OF THE AUDIT COMMITTEE OF THE BOARD OF DIRECTORS | 12 |
| EXECUTIVE OFFICERS | 12 |
| CORPORATE GOVERNANCE | 13 |
| COMMITTEES OF THE BOARD | 16 |
| EXECUTIVE COMPENSATION | 18 |
| DIRECTOR COMPENSATION | 29 |
| SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT | 30 |
| CERTAIN RELATIONSHIPS AND RELATED PERSON TRANSACTIONS | 31 |
| STOCKHOLDERS’ PROPOSALS | 33 |
| OTHER MATTERS | 34 |
| SOLICITATION OF PROXIES | 34 |
i
3 Columbus Circle
New York, NY 10019
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.